Literature DB >> 16632633

Update in cystic fibrosis 2005.

Frank J Accurso1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16632633      PMCID： PMC2662914          DOI： 10.1164/rccm.2601006

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  43 in total

1.  Embryonic stem cells generate airway epithelial tissue.

Authors:  Christelle Coraux; Béatrice Nawrocki-Raby; Jocelyne Hinnrasky; Claire Kileztky; Dominique Gaillard; Christian Dani; Edith Puchelle
Journal:  Am J Respir Cell Mol Biol       Date:  2004-12-02       Impact factor: 6.914

2.  The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.

Authors:  Kai Du; Manu Sharma; Gergely L Lukacs
Journal:  Nat Struct Mol Biol       Date:  2004-12-26       Impact factor: 15.369

3.  Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.

Authors:  Allan L Berger; Mutsuhiro Ikuma; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

4.  Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis.

Authors:  Guoshun Wang; Bruce A Bunnell; Richard G Painter; Blesilda C Quiniones; Susan Tom; Nicholas A Lanson; Jeffrey L Spees; Donna Bertucci; Alexandra Peister; Daniel J Weiss; Vincent G Valentine; Darwin J Prockop; Jay K Kolls
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

5.  TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.

Authors:  Catherine M Greene; Tomás P Carroll; Stephen G J Smith; Clifford C Taggart; James Devaney; Siobhan Griffin; Shane J O'neill; Noel G McElvaney
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

6.  Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis.

Authors:  Susan S Baker; Drucy Borowitz; Linda Duffy; Laura Fitzpatrick; Joyce Gyamfi; Robert D Baker
Journal:  J Pediatr       Date:  2005-02       Impact factor: 4.406

Review 7.  Cystic fibrosis since 1938.

Authors:  Pamela B Davis
Journal:  Am J Respir Crit Care Med       Date:  2005-08-26       Impact factor: 21.405

8.  Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.

Authors:  Hal A Lewis; Xun Zhao; Chi Wang; J Michael Sauder; Isabelle Rooney; Brian W Noland; Don Lorimer; Margaret C Kearins; Kris Conners; Brad Condon; Peter C Maloney; William B Guggino; John F Hunt; Spencer Emtage
Journal:  J Biol Chem       Date:  2004-11-03       Impact factor: 5.157

9.  Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis.

Authors:  Paul Aurora; Andrew Bush; Per Gustafsson; Cara Oliver; Colin Wallis; John Price; John Stroobant; Siobhan Carr; Janet Stocks
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

10.  Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.

Authors:  Andrew M Jones; Mary E Dodd; John R W Govan; Catherine J Doherty; Catherine M Smith; Barbara J Isalska; A Kevin Webb
Journal:  Am J Respir Crit Care Med       Date:  2004-11-12       Impact factor: 21.405
View more
  9 in total

Review 1.  A review of non-cystic fibrosis pediatric bronchiectasis.

Authors:  Eric J Boren; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

2.  Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Alessandro Luciani; Valeria Rachela Villella; Speranza Esposito; Manuela Gavina; Ilaria Russo; Marco Silano; Stefano Guido; Massimo Pettoello-Mantovani; Rosa Carnuccio; Bob Scholte; Antonella De Matteis; Maria Chiara Maiuri; Valeria Raia; Alberto Luini; Guido Kroemer; Luigi Maiuri
Journal:  Autophagy       Date:  2012-08-09       Impact factor: 16.016

3.  Caregiver perspectives on discussions about the use of intensive treatments in cystic fibrosis.

Authors:  Elisabeth P Dellon; Mitchell D Shores; Katherine I Nelson; Joanne Wolfe; Terry L Noah; Laura C Hanson
Journal:  J Pain Symptom Manage       Date:  2010-09-09       Impact factor: 3.612

4.  In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.

Authors:  Andreas Hector; Matthias Kappler; Matthias Griese
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

5.  Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator.

Authors:  V R Villella; S Esposito; E M Bruscia; M Vicinanza; S Cenci; S Guido; M Pettoello-Mantovani; R Carnuccio; M A De Matteis; A Luini; M C Maiuri; V Raia; G Kroemer; L Maiuri
Journal:  Cell Death Differ       Date:  2013-05-17       Impact factor: 15.828

Review 6.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

7.  A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.

Authors:  Chirag Kariya; Heather Leitner; Elysia Min; Christiaan van Heeckeren; Anna van Heeckeren; Brian J Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-16       Impact factor: 5.464

8.  Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals.

Authors:  Parisa Vali; Fereshteh Shahcheraghi; Maryam Seyfipour; Maryam Alsadat Zamani; Mohammad Reza Allahyar; Mohammad Mehdi Feizabadi
Journal:  J Clin Diagn Res       Date:  2014-01-12

9.  Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.

Authors:  Henrique Douglas M Coutinho; Vivyanne S Falcão-Silva; Gregório Fernandes Gonçalves
Journal:  Int Arch Med       Date:  2008-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.